BNGO: Bionano Genomics, Inc. Common Stock Company Profile & Statistics

About

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents. BioNano Genomics, Inc. is based in San Diego, United States.

Info & Links

CEO

R. Erik Holmlin

Headquarters

9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO, CA 92121, UNITED STATES

Auditor

BDO USA, P.C.

Share holders

Employees

344

Bionano Genomics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

8.99M

Enterprise Value

18.97M

Enterprise Value/EBITDA(ttm)

-0.23

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.31

Price to Book(mrq)

0.16

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-12.71%

Operating Margin(ttm)

-356.92%

Profit Margin(ttm)

-426.27%

Return on Equity(ttm)

-154.45%

Return on Invested Capital(ttm)

-184.14%

Return on Assets(ttm)

-80.78%

Income Statement

Revenue(ttm)

33.33M

Revenue Per Share(ttm)

19.57

Gross Profit(ttm)

-598.00K

EBITDA(ttm)³

-83.03M

Net Income Available to Common(ttm)

-135.78M

Diluted EPS(ttm)

-138.92

Share Statistics

Beta (5Y Monthly)

2.13

52-Week Change

-92.39%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

1.70M

Dividend Yield

0.00%

Float⁴

1.92M

% Held by Insiders

1.60%

% Held by Institutions

11.35%

Balance Sheet

Total Cash(mrq)

22.95M

Total Cash Per Share(mrq)

13.48

Total Debt(mrq)

18.77M

Total Debt/Equity(mrq)

38.40%

Current Ratio(mrq)

1.43%

Quick Ratio(mrq)

0.99%

Book Value Per Share(mrq)

33.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-43.53

Free Cash Flow(ytd)

-62.52M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BNGO

Bionano Genomics, Inc. Common Stock

Bionano Genomics, Inc. Common Stock Profile